Reason for request
Renewal of inclusion on the list of reimbursable medicinal products.
Clinical Benefit
| Insufficient |
The actual benefit of the proprietary medicines MAGNE B6 for oral administration, is insufficient to be reimbursed by national solidarity. |
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
tBMGPZcvDdvMsAQV
